Post by DSV - Global Transport and Logistics

Geopolitical volatility is no longer a distant risk for the pharma and biotech industry. It’s a daily operational reality. From disruptions in key trade corridors to shifting regulatory landscapes and regionalisation trends, supply chains are under increasing pressure. Recent events have shown how quickly disruptions can escalate and how significantly they can impact both patient outcomes and business performance. In this environment, resilience is no longer just about contingency planning – it’s about execution at speed, without ever compromising compliance, GDP or patient safety. Consequently, the ability to reroute, reassess risk and maintain visibility in real time is no longer a competitive advantage, but a requirement. See below or visit our website to discover how pharma supply chains can adapt to this new reality by focusing on five critical capabilities: https://ow.ly/Hfg750Zg8CA